ClearBridge Investments’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74M Sell
667,118
-34,734
-5% -$459K 0.01% 500
2026
Q1
$9.67M Sell
701,852
-11,362
-2% -$171K 0.01% 474
2025
Q4
$12.9M Buy
713,214
+256,876
+56% +$4.61M 0.01% 457
2025
Q3
$8.46M Buy
+456,338
New +$7.17M 0.01% 534

Other funds holding CLBT

ClearBridge Investments's CLBT Position: Q2 2026 in Review

ClearBridge Investments reduced its Cellebrite (CLBT) stake by 4.9% in Q2 2026, selling an estimated $459K and leaving 667,118 shares worth $9.74M. The position accounts for 0.01% of the portfolio, ranked #500.

ClearBridge Investments first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $12.9M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • ClearBridge Investments held 667,118 shares of Cellebrite worth $9.74M as of Q2 2026.
  • ClearBridge Investments sold 34,734 Cellebrite shares in Q2 2026, an estimated $459K.
  • Cellebrite made up 0.01% of ClearBridge Investments's portfolio in Q2 2026, its #500 holding.
  • ClearBridge Investments first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • ClearBridge Investments's Cellebrite position peaked at $12.9M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.